Contrive Datum Insights has published "Single Use Bioprocessing Systems Market Size, Share & Industry Analysis, By Product type (Single-use media bags and containers, Single-use assemblies, Single-use bioreactors, Disposable mixers, Other products), Application (Monoclonal antibodies (mAbs), Vaccines, Cell therapies, Other products), Work flow (Upstream Bioprocessing, Fermentation, Downstream Bioprocessing), Method (Filtration, Storage, Cell culture, Mixing, Purification), End-user (Biopharmaceutical Manufacturers, CMOs & CROs, In-house Manufacturers, Academic & Clinical Research Institutes), and Regional Forecast, 2026-2034". The study sizes the global single use bioprocessing systems market at USD 29.5 billion in 2025 and projects growth from USD 33.1 billion in 2026 to USD 80.3 billion by 2034, a compound annual growth rate of 11.72% across the forecast period.
Single-use bioprocessing systems are pre-sterilized, disposable bags, assemblies, bioreactor vessels, mixers and connectors used in place of fixed stainless steel equipment across the manufacture of biologic drugs. They are supplied as bags and containers for fluid storage and transport, tubing and connector assemblies, stirred or wave-mixed disposable bioreactors, and disposable mixing systems, each discarded and replaced between production batches rather than cleaned and revalidated. Buyers are biopharmaceutical manufacturers, contract manufacturing and research organizations, in-house production units and academic or clinical research institutes producing monoclonal antibodies, vaccines and cell therapies.
Growth in monoclonal antibody and biologics manufacturing capacity
Growth in monoclonal antibody and biologics manufacturing capacity is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 11.72% a year, the product type lines exposed to it move fastest: Single-use bioreactors compounds at 13.3%, taking its share of revenue from 30% to 34% and its value from USD 8.85 billion to USD 27.3 billion.
On the upside, the study's bull case assumes biologics pipeline approvals and CMO capacity expansions run ahead of the base case, accelerating conversion from stainless steel to single-use systems across all regions, which would take 2034 revenue to USD 94.75 billion against the USD 80.3 billion base case.
Against that, biologics approval timelines slow and capital spending on new biomanufacturing capacity is deferred, keeping stainless steel systems in service longer than the base case assumes. On that reading 2034 revenue stops at USD 68.26 billion. The weight of the problem sits in Single-use media bags and containers: 32% of 2025 revenue growing at 10.48%, well under the market's 11.72%.
Single-use media bags and containers Scale Against Single-use bioreactors Momentum
The product type axis, not the regional one, is what divides the field. Single-use media bags and containers is the volume position, 32% of 2025 revenue at USD 9.44 billion, holding 29% through 2034, and it is defended by scale. Single-use bioreactors is the growth position at 13.3%, and it is open. Strength in one does not carry into the other.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Application | Monoclonal antibodies (mAbs) | 48% · USD 14.16 billion | Cell therapies 16.92% |
| Work flow | Upstream Bioprocessing | 42% · USD 12.39 billion | — |
| Method | Cell culture | 28% · USD 8.26 billion | — |
| End-user | Biopharmaceutical Manufacturers | 50% · USD 14.75 billion | CMOs & CROs 13.33% |
- North America was the largest region in 2025, holding 42% of global revenue at USD 12.39 billion and reaching USD 29.71 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 22% in 2025 to 29% in 2034, with revenue growing from USD 6.49 billion to USD 23.29 billion.
- Middle East and Africa remains the smallest region throughout, at 3% of 2025 revenue and 3.5% by 2034.
- By product type, the largest line in 2025 was Single-use media bags and containers, at 32% of revenue and USD 9.44 billion.
- Single-use bioreactors is projected to grow at 13.3% over the forecast period, the fastest of any product type line.
- The United States is the largest single country market at USD 10.53 billion in 2025, 35.69% of global revenue.
Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by product type, and by application, work flow, method and end-user. The headline total carries bear, base and bull cases at USD 68.26 billion and USD 94.75 billion by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.